Results 131 to 140 of about 3,675 (156)
Some of the next articles are maybe not open access.
Micropulse Transscleral Diode Laser Cyclophotocoagulation in the Treatment of Refractory Glaucoma
Clinical and Experimental Ophthalmology, 2010Abstract Background: Transscleral diode laser cyclophotocoagulation (TSCPC) is an established method of treatment for refractory glaucoma, but is associated with significant complications. This study evaluates the efficacy and safety of a new form of TSCPC using micropulse diode laser and ...
Paul Tk Chew
exaly +3 more sources
Journal of Glaucoma, 2021
Precis: Micropulse transscleral cyclophotocoagulation (MP-TSCPC) with a 120-second setting reduces intraocular pressure (IOP) with a 6-month success of 45.5%. Only late (>6 mo) failure seem to present a benefit for retreatment. Purpose:
Chamard, Chloé +3 more
openaire +2 more sources
Precis: Micropulse transscleral cyclophotocoagulation (MP-TSCPC) with a 120-second setting reduces intraocular pressure (IOP) with a 6-month success of 45.5%. Only late (>6 mo) failure seem to present a benefit for retreatment. Purpose:
Chamard, Chloé +3 more
openaire +2 more sources
Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma
European Journal of Ophthalmology, 2019Purpose: To describe our clinical experience with the efficacy and safety of micropulse transscleral cyclophotocoagulation as a treatment for glaucoma. Methods: In this retrospective case series, we reviewed the charts of 95 ...
Alexander T, Nguyen +2 more
openaire +2 more sources
Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma
Lasers in Medical Science, 2015Glaucoma is the leading cause of irreversible blindness worldwide. The goal of this study was to describe our experience with the novel micropulse transscleral cyclophotocoagulation (MP-TSCPC; IRIDEX IQ810 Laser Systems, CA) in patients with advanced glaucoma. Patients with advanced glaucoma who underwent MP-TSCPC were included in our study.
Sarah, Kuchar +3 more
openaire +2 more sources
A Case of Choroidal and Vitreous Hemorrhage Following Micropulse Transscleral Cyclophotocoagulation
Journal of Glaucoma, 2020Choroidal hemorrhages involve bleeding into the potential space between the choroid and sclera and are a serious ocular complication. Common causes of choroidal hemorrhages include intraocular surgeries, such as scleral buckling, cataract extractions, and glaucoma filtering procedures, or trauma.
Khalid M, Aldaas +2 more
openaire +2 more sources
Efficacy and Safety of Micropulse® Transscleral Cyclophotocoagulation in Glaucoma
Archivos De La Sociedad Espanola De Oftalmologia, 2018To report the results using Micropulse® transscleral cyclophotocoagulation (Iridex) in the treatment of glaucoma.Retrospective study in adult patients with glaucoma with at least 6 months of follow-up, and only one session of Micropulse®. The same surgical technique was used in all cases. The only laser parameter that could vary was the total treatment
F G, Sanchez +6 more
exaly +3 more sources
Severe Inflammation and Hyphema After Micropulse Diode Transscleral Cyclophotocoagulation
Journal of Glaucoma, 2020Purpose:To describe vision-threatening complications after micropulse diode transscleral cyclophotocoagulation (MP-TSCPC).Methods:Retrospective case series. Medical charts of patients who underwent MP-TSCPC and developed visually significant inflammation and hyphema after the procedure were reviewed. Patients were seen at the Upstate Medical University
Swetha, Dhanireddy +7 more
openaire +2 more sources
Outcomes of Micropulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision
Journal of Glaucoma, 2019Precis: This study is the first to report micropulse transscleral cyclophotocoagulation (MP-TSCPC) use in only good vision patients. MP-TSCPC significantly reduced intraocular pressure (IOP) and glaucoma medication use without any significant reduction in visual acuity at every postoperative follow-up point.
Mayuri, Borgohain +4 more
openaire +4 more sources
Micropulse Transscleral Cyclophotocoagulation in the Combine Treatment of Neovascular Glaucoma
GlaucomaNews, 2020Introduction. Neovascular glaucoma (NVG) is one of the most prognostically unfavorable forms of the glaucomatous process. The leading pathogenetic mechanism for the development of NVH is hypoxia of the inner layers of the retina, leading to the development of endothelial vascular growth factors (VEGF), which induce neovascular proliferation.
N.S. Khodzhaev +2 more
openaire +1 more source
Micropulse Transscleral Cyclophotocoagulation (mTSCPC)
2021Nathan M. Radcliffe, Tarika Thareja
openaire +1 more source